Skip to main content
Sign In |
  Help (new window)

Home

Go SearchAdvanced Search
Home
The CAVD
The Research
The Grantees
  
Home > Conference_Abstracts  

Conference_Abstracts

View All Site Content

Modify settings and columns
  
View: 
Expand/Collapse CAVD Grantee : Gallo VDC ‎(1)
Kopycinski, J
Multiparametric Flow Analysis of HIV-specific CD8 T-cell Mediated Virus InhibitionUse SHIFT+ENTER to open the menu (new window).
Keystone 2010, Banff Canada
Expand/Collapse CAVD Grantee : Greenberg MIL ‎(5)
Blattman, J
The Problems with Persistent Viral InfectionsUse SHIFT+ENTER to open the menu (new window).
Workshop on the Immunological Basis of Vaccine Efficacy 2009 - Seattle
Blattman, J
Use of Retinoic Acid as an Adjuvant during Vaccination Results in Increased Central Memory T cells and also Imprints Gut Mucosal Homing Properties to Memory T CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Greenberg, P
Creating a mouse model for human immune responses: Transferring human genes rather than human cellsUse SHIFT+ENTER to open the menu (new window).
Grand Challenge Meeting - 2009
Tan, X
Retinoic acid as an adjuvant to imprint mucosal homing properties to vaccine-induced T cellsUse SHIFT+ENTER to open the menu (new window).
American Association of Immunology 2009 - Seattle
Tan, X
Retinoic acid as an adjuvant to imprint mucosal homing properties to vaccine-induced T cells Use SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Expand/Collapse CAVD Grantee : Haynes VDC ‎(30)
Alam, S
Phospholipid binding and neutralization by anti-gp41HIV-1 Envelope antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Alam, S. Munir
Induction of antibodies with specificity for gp41 neutralizing epitopes by membrane anchored gp41 immunogensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010
Alam, S. Munir.
Reverted unmutated ancestor 2F5 VH2-5 alleles differentially bind gp41 and bacterial antigens: a potential genetic basis for gp41 neutralizing B cell responses Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010
Alam, SM
The role of lipid reactivity of HIV-1 gp41 membrane proximal antibodies in neutralization of HIV-1: Novel liposome based immunogen designUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Chen, W
Human domain antibodies targeting conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Chen, W
Monoclonal antibodies from patient with acute HIV-1 infection Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Davis, KL
HIV-2/HIV-1 Envelope Chimeras Detect High Titer Broadly Reactive HIV-1 V3-Specific Antibodies in Human PlasmaUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Desaire, H
Glycopeptide analysis of individual glycosylation sites of HIV envelope oligomers that induce breadth in neutralizing antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Desaire, H
Glycosylation: An important factor in Env diversityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Dimitrov, DS
All Known Cross-reactive HIV-1 Neutralizing Antibodies Are Highly Divergent from Germline and their Elicitation May Require Prolonged Periods of TimeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Geonnotti, A
Endotoxin-mediated Inhibition of HIV-1 in Peripheral Blood Mononuclear Cells but Not in TZM-bl Cells: A Cautionary Note for Neutralizing Antibody AssaysUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Holl, T
Murine B cells that bind to neut 2F5 MPER epitope frequent in immature B-cell compartment, undetect in mature splenic poolsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Holl, TM
Generation of Robust Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Holl, TM
Generation of Antibody Responses to HIV-1 Membrane Proximal External Region (MPER) AntigenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kong, R
Epitope Mapping of Neutralizing Antibody 1.7A on the Human Immunodeficiency Virus Type 2 gp160 GlycoproteinUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Liao, HX
Characterization of the Plasma Cell Repertoire in Acute HIV-1 Infection (AHI)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Liu, W
Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody ResponsesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Moody, MA
Anti-lipid Human Monoclonal Antibodies Inhibit HIV-1 Infection of PBMC By Binding to Host CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Munshaw, M
A Large-Scale Analysis of Immunoglobulin Sequences Derived From Plasmablasts/Plasma Cells in Acute HIV-1 Infection SubjectsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Munshaw, S
A Large-Scale Analysis of Immunoglobulin Sequences Derived From Plasmablasts/Plasma Cells in Acute HIV-1 Infection SubjectsUse SHIFT+ENTER to open the menu (new window).
Multi-Scale Modeling of Host/Pathogen Interactions 2009 - Pittsburgh
Nicely, Nathan
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane proximal external regionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010, Atlanta, Georgia
Reardon, P.
Characterization of the membrane proximal domain from HIV gp41 coat protein in detergent micelles with multi-dimensional NMRUse SHIFT+ENTER to open the menu (new window).
World Wide Magnetic Resonance Conference
Reardon, P.N.
Characterization of a membrane anchored HIV MPER peptide with multi-dimensional NMRUse SHIFT+ENTER to open the menu (new window).
ENC, April 2010, Florida
Verkoczy, L
Characterization of B cell superantigen activity by membrane proximal external region 2F5 epitope in HR2 peptide-immunized miceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Verkoczy, L
Immunological Tolerance Prevents the Expression of a Broadly Reactive Neutralizing HIV-1 AntibodyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Verkoczy, Laurent
Dissection of the contributions of Immunoglobulin light chains and MPER specificity in counterselection of B cells expressing the Broadly Neutralizing antibody 2F5Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010
Wiehe, K
Simulation of an MPER Peptide Samples Epitope Conformations of Two Broadly Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Xiao, X
Guiding the immune system through complex maturation pathways – a novel multi-immunogen approach for elicitation of known broadly neutralizing antibodies Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Zhang, M
Cross-Reactive HIV-Neutralizing Human Monoclonal Antibody which Recognizes Novel Conformational Epitope on gp41, Lacks Reactivity against Self AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Zhu, Z
New broadly neutralizing human monoclonal antibodies targeting the 2F5 epitopeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Expand/Collapse CAVD Grantee : Ho VDC ‎(5)
Franco, D
Evaluation of the Yellow Fever Virus Vaccine Strain 17D as a New Vector for HIV-1 Vaccine DevelopmentUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Franco, D
Immunogenicity Studies of Chimeric Yellow Fever 17D Viruses Carrying HIV-1 p24 Antigen Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Vasan, S
Safety, Tolerability and Acceptability of Electroporation to Deliver ADVAX, a Clade C/B’ DNA-Based Candidate HIV-1 Vaccine, to Healthy VolunteersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Vasan, S
In Vivo Electroporation Enhances the Immunogenicity of ADVAX, a DNA-based HIV-1 Vaccine Candidate, in Healthy VolunteersUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Vasan, S.
In Vivo Electroporation Enhances the Immunogenicity of ADVAX, a DNA-based HIV-1 Vaccine Candidate, in Healthy Volunteers.Use SHIFT+ENTER to open the menu (new window).
DNA Vaccines 2010
Expand/Collapse CAVD Grantee : Koup VIMC ‎(12)
 Kopycinski, Jakub
Multiparametric Flow Analysis of HIV-specific CD8 T-cell Mediated Virus InhibitionUse SHIFT+ENTER to open the menu (new window).
Keystone, HIV vaccines and Viral Immunity, March 21-26th 2010 Banff, Canada
Bourne, V
Developing assays to characterise and phenotype long lived memory T cellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
De La Rosa, M
B cells do not play a major role in SIVmac239 nef-mediated protection against SIVmac239 challengeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
De La Rosa, M
B cells play a marginal role in SIV mac 239 nef-mediated protection against SIV mac 230 challengeUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Ferrari, G
Establishing PBMC Repository for T Cell Assays Optimization and Proficiency Testing in Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) Laboratories.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Gilmour, J
Excellent concordance between IFN-gamma ELISpot results in two Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) Laboratories.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Harari, A
Cytotoxic activity of virus-specific CD8 T-cells correlates with perforin and GrmB expression and differentiation stage but not with GrmA or GrmKUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Harari, A
Cytotoxic Activity of Virus-Specific CD8 T-Cells Correlates with Perforin and GrzB Expression and Differentiation Stage but not with GrzA, GrzKUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Huang, Y
Statistical Design and Analysis of the CAVD-VIMC Elispot Transfer Study 001 Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
McElrath, MJ
Vaccine-Induced Immunity in T-Cell Based Candidate HIV VaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Pantaleo, G
Immune Correlates of Protection to HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Ssemaganda, A
Developing the capacity for multifunctional lymphocyte analysis at the UVRI-IAVI laboratoryUse SHIFT+ENTER to open the menu (new window).
Uganda AIDS Conference 2008 - Entebbe
Expand/Collapse CAVD Grantee : Lehner VDC ‎(2)
Mörner A
Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaquesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wang, Y
Allogeneic stimulation of the innate anti-viral factor APOBEC3G expression in human memory CD4+ T cells and prevention of SHIV infectivity in macaques immunized with recombinant HLA antigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Letvin VDC ‎(17)
Barouch, D
Novel Adenovirus Vector-Based Vaccines for HIV-1Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Barouch, Dan
HIV-1 Mosaic Antigens Expand Cellular Immune Breadth and Depth in Rhesus MonkeysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Barouch, Dan
First-in-Human Phase 1 Safety and Immunogenicity of an Adenovirus Serotype 26 HIV-1 Vaccine VectorUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bradley, RR
Hexon hypervariable regions 4-7 contain important Ad5-specific neutralizing antibody epitopesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Kaufman, DR
Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Ko, SY
Enteric adenovirus 41 vector enhances induction of intestinal cellular immunity by oral primingUse SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Ko, SY
Development of recombinant adenovirus 28 vectors for HIV vaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Masek-Hammerman, K
Mucosal trafficking of vector-specific CD4+ T lymphocytes following Adenovirus serotype 5 vaccination of rhesus monkeys. Use SHIFT+ENTER to open the menu (new window).
Keystone 2010
Maxfield, LF
Impact of Rare Adenovirus Seroprevalence on HIV-1 Acquisition in the Step StudyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Nabel, Gary J.
AIDS Vaccine Clinical Evaluation: Where Are We and Where Can We Go?Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Nabel, GJ
Prospects for a Global AIDS VaccineUse SHIFT+ENTER to open the menu (new window).
AAAS Meeting 2008 - Boston
Nabel, GJ
No Evidence for Consistent Virus-specific Immunity in Simian Immunodeficiency Virus Exposed, Uninfected Rhesus Monkeys. Use SHIFT+ENTER to open the menu (new window).
2007 Annecy
Nabel, GJ
Criteria for Advancement of Novel Vaccine CandidatesUse SHIFT+ENTER to open the menu (new window).
Keystone 2008 - Banff
Rhee, EG
Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependenceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wang, L
rAd prime/rLCMV boost regimen induces long-lasting HIV-1-spcific humoral and cellular immune responses in mice. Use SHIFT+ENTER to open the menu (new window).
Keystone 2010
Wu, L
Development of Outer Domain Env Immunogens to Elicit Broadly Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Zullo, AJ
Identifying mycobacterial factors modulating autophagy.Use SHIFT+ENTER to open the menu (new window).
Southeastern Tuberculosis meeting, 2010, Durham, NC
Expand/Collapse CAVD Grantee : McElrath VDC ‎(8)
Andersen-Nissen, E
Characterizing the innate immune response in HVTN 071, a trial using MRKAd5 gag/pol/nef from the STEP studyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Bhardwaj , N
Suppression of human dendritic cell function during acute HIV infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Manches, O
HIV-activated plasmacytoid dendritic cells induce regulatory T cells through an indoleamine 2,3 dioxygenase dependent mechanismUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Manches, O
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanismUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Pulendran, B
Innate control of adaptive immunity to vaccines and pathogensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Seder, R
Primary Immunization Influences the Magnitude, Quality and Breadth of Gag Specific T Cell Responses Following an rAd-5 BoostUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Vogt, J
Development of an Ad5 ELISA: Beyond Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Zak, D
Application of systems biology to identify predictors of HIV Vaccine ImmunogenicityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Expand/Collapse CAVD Grantee : Montefiori VIMC ‎(55)
Anderson, J
The Genetic Complexity of HIV-1 env in Subtype B and C Transmission PairsUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting – Boston, MA  - 2009
Bandawe, G
Genetic characterization and determination of multiplicity of infection using single genome amplification of recently transmitted HIV-1 env variants from a cohort with multiple circulating HIV-1 subtypes in Mbeya, TanzaniaUse SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Bar KB
Multiplicity of infection by HIV-1 in injection drug users, men who have sex with men and heterosexuals.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bar KJ
Neutralizing Antibody Responses Against Conformational Envelope Epitopes in Early HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Binley, J
Profiling the Specificity of Neutralizing Activity in a Panel of HIV+ Plasmas from Subtypes B and C Chronic InfectionsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Binley, J.M.
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody NeutralizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Binley, JM
Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donorsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Borges, AR
Recombination of HIV-1 gp160 clones with viral backbone DNA through co-transfection to produce pseudoviruses can create replication competent virusesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Bronwen, E
Generation of multiple HIV-1 subtype C envelope single-genome amplification (SGA) products from recent infection cervico-vaginal lavage samplesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brown, BK
Characterization of the influence of PBMC donor parameters on HIV-1 PBMC neutralization assay variability: implications for assay standardizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brown, BK
Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assaysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Chen, Y.
Limited introductions and genetic variation of HIV-1 in a MSM cohort in China. Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Chenine, A-L
Full-length IMC expressing Renilla Luciferase for neutralization assay using PBMCUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Crooks, ET
Relationship of HIV-1 and SIV Envelope Glycoprotein Trimer Occupation and NeutralizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Eller, LA
Breadth and Magnitude of Neutralizing Antibody Responses in Subjects Infected with HIV-1 Subtype D or D Containing Recombinants in Rakai District, UgandaUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Geonnotti, A
Endotoxin-mediated Inhibition of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells but Not in TZM-bl Cells: A Cautionary Note for Neutralizing Antibody AssaysUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Geonnotti, A. R.
Computationally identified mutations suspected to cause gp120 charge inversion and gp41-mediated allosteric effects impact IgG1b12 susceptibilityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Gnanakaran, S
Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Gray, E
Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralizationUse SHIFT+ENTER to open the menu (new window).
Keystone 2010, Banff Canada
Hart, Lydia
A novel high throughput quantitative platform to detect HIV-1 and SIV-specific Antibody Dependent Cellular Cytotoxicity (ADCC)-mediating antibody responses.Use SHIFT+ENTER to open the menu (new window).
4th Annual Measurement of Antigen Specific Immune Reponses (MASIR) Conference -2010
Hu, X.
Profiles of neutralizing antibody responses in chronically HIV-1 clade B’ infected treatment-naïve former plasma donors in China Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Iqbal, HS
Robust Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India: Potential Avenues for Vaccine Design Use SHIFT+ENTER to open the menu (new window).
IAS Conference, Vienna, July 2010
Karnasuta, C.
Magnitude and Breadth of the Neutralizing Antibody Response in RV144Use SHIFT+ENTER to open the menu (new window).
Institute of Human Virology 12th Annual International Meeting
Karnasuta, Chitraporn
Magnitude and Breadth of the Neutralizing Antibody Response in RV144Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine, 2010, Atlanta, GA USA
Koch, S.
First implementation of an automated cell culture and transfection system for HIV-1 Env-pseudotyped virus production Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Kulkarni, S
Highly Complex Neutralization Determinants on a Monophyletic Lineage of Newly Transmitted Subtype C HIV-1 Env Clones from IndiaUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Li, H
Molecular Cloning and Biological Characterization of Full Length Transmitted/ Founder Viruses from Injection Drug Users (IDU), Men Who have Sex with Men (MSM) and Heterosexuals (HSX)Use SHIFT+ENTER to open the menu (new window).
CROI San Francisco, 2010
Madiga, M
Development of intra- and inter-subtype cross-neutralizing antibodies in HIV-1 subtype C infection Use SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Madiga, M.
Evolution of cross-neutralizing antibodies in HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Nofemela, A
Characterization of genotypic properties of transmitted HIV-1 variants across different subtypesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Nofemela, A
Genetic characterization of transmitted HIV-1 env variants from Mbeya, TanzaniaUse SHIFT+ENTER to open the menu (new window).
Abstract:  3rd Annual South African AIDS Conference, 2009, Durban
Nofemela, A.
The entry efficiency of transmitted HIV-1 variants from Mbeya, Tanzania plays a role in disease progressionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Oballah, P.
B cell depletion, CD4 counts and viral load impact on ADCC, binding antibodies and neutralizing antibody profiles in HIV-1 subtype A chronically infected UgandansUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Ochsenbauer, C.
Development of New Virologic Reagents: Improved Immune Monitoring Tools and Assays Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Ouma, B
Evolution of Autologous Neutralizing Antibody Responses in Subjects Infected with HIV-1 Subtype D in Rakai District, UgandaUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Ozaki, Daniel A.
Bringing Academic Research and Development Laboratories to Perform GCLP-compliant studies for Human Clinical Trials: A challenge for assay implementation and revalidationUse SHIFT+ENTER to open the menu (new window).
Society for Quality Assurance Annual Meeting –Apr 2010 - Cincinnati, OH
Ozaki, Daniel A.
Bringing Academic Research and Development Laboratories to Perform GCLP-compliant studies for Human Clinical Trials: A challenge for assay implementation and revalidationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Pollara, J.
High titers of cross-clade ADCC-mediating antibodies are detectable in plasma samples collected from individuals with broadly neutralizing antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Ren, Li
Neutralization of HIV-1 cell-cell spreadUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Revilla, A
Improved Protocol for Amplification from Plasma and Cloning of Functional Full-length Envelopes of Different Genetic Forms of HIV-1Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Revilla, A
Development of a panel of functional HIV-1 subtype G full-length envelope clones obtained from plasma of infected individualsUse SHIFT+ENTER to open the menu (new window).
International AIDS Society 2009 - Cape Town
Robinson, JE
Human and Rhesus MAbs Recognizing Distinct Groups of Epitopes that Elicit Neutralizing Antibodies against Autologous HIV-1 StrainsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Salazar, M
Identification and Chemical Synthesis of a Complete Infectious Transmitted HIV-1 GenomeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Salazar-Gonzalez, JF
Identification of Transmitted/Founder Complete HIV-1 Genomes in Subjects With Acute HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Sarzotti-Kelsoe, M
Evaluation and Recommendations on Good Clinical Laboratory PracticeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Shen, X
A Mutation in HIV-1 gp41 Envelope Membrane Proximal Region Increases Neutralizing Antibody Potency and in the Context of Peptide-Lipid Conjugates Binds to 2F5 mAb more StablyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Thebus, Ruwayhida
Genetic characteristics of HIV-1 envelope associated with broadly cross-reactive neutralizing antibody responsesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Thomson, M.M.
Phenotypic characterization of a panel of HIV-1 subtype G functional envelope clonesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Todd, C A
Development and Implementation of an International Proficiency Testing Program for the Neutralizing Antibody Assay for HIV-1 in TZM-bl CellsUse SHIFT+ENTER to open the menu (new window).
Society for Quality Assurance Annual Meeting –Apr 2010 - Cincinnati, OH
Todd, CA
Development and Implementation of an International Proficiency Testing Program for a Neutralizing Antibody Assay for HIV-1 in TZM-bl CellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Tomaras, G.D.
Specificities of Elite Broadly Neutralizing Sera from HIV-1-Infected Individuals Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Wei, Q.
HIV-1 Infection mediated by cell-cell interaction is resistant to neutralizing antibodyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Wieczorek, L
HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specificUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Yates, NL
Differential Regulation of HIV-Specific IgG Subclass Antibodies Following Infection Versus VaccinationUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting - Boston
Zhao, C.
Genotypic and phenotypic characteristics of CRF01_AE HIV‐1 virus env genes from early infected individuals Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 - Vienna
Expand/Collapse CAVD Grantee : Pantaleo VDC ‎(8)
 Bart, Pierre-Alexandre
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the randomized multicentre EV03/ANRS Vac20 Phase I/II TrialUse SHIFT+ENTER to open the menu (new window).
CROI 2010, San Francisco
David, D
Assay conditions with primary HIV-1 isolates giving neutralization rates proportional to Ab concentration and in vivo protectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Delaloye, J
Role of Toll-like receptor (TLR), RIG-I-like receptor (RLR) and Nod-like receptor (NLR) pathways in innate immune responses elicited by poxvirusUse SHIFT+ENTER to open the menu (new window).
Toll 2008 - Lisbon
Kibler, K
Replication competent attenuated strains of vaccinia virus as potential vaccine vectors.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Kibler, K.V.
Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccinesUse SHIFT+ENTER to open the menu (new window).
Poxvirus 2010
Kibler, KV
Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccinesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Köstler, J
HIV-1 Vaccine Design based on Human Vaccine Trials to Improve Gag, Pol, Nef and Env Specific Immune ResponsesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Quakkelaarm ED
Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitroUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Parks VDC ‎(4)
Jurgens, Christy
Novel VSV-SIV Chimeric Vaccine Candidates Use SHIFT+ENTER to open the menu (new window).
Keystone - Immunologic mechanisms of vaccination, 2010, Seattle WA
Parks, Christopher, L
DEVELOPMENT OF VSV VECTORS FOR DELIVERY OF ENV IMMUNOGENS. Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 Conference, 2010, Atlanta, GA, USA
Parks, Christopher, L
DEVELOPMENT OF LIVE VSV VECTORS FOR DELIVERY OF AIDS VACCINES. Use SHIFT+ENTER to open the menu (new window).
14th International NegativeStrand Virus Meeting, 2010, Bruges, Belgium
Zhang, Xinsheng
A recombinant canine distemper virus vector expressing SIV Gag replicates in ferret gut-associated lymphoid tissues and is immunogenic.Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2010 Conference, 2010, Atlanta GA
Expand/Collapse CAVD Grantee : Patterson VDC ‎(14)
Athanasopoulos Takis
Assessment of Ad vectors expressing full or fragmented HIV genetic componentsUse SHIFT+ENTER to open the menu (new window).
International Union of Biochemistry and Molecular Biology 2009
Athanasopoulos Takis
Development and assessment of thermo-stable Adenovirus (Ad)-based vaccines expressing ubiquitinated and genetically fragmented HIV/SIV genetic componentsUse SHIFT+ENTER to open the menu (new window).
British Society for Gene Therapy, 2010, Royal Holloway University of London
Athanasopoulos, T
Ubiquitination and segmentation of HIV genetic components: Aiming towards an HIV vaccine inducing broad(er) T cell immune responsesUse SHIFT+ENTER to open the menu (new window).
European Society for Gene and Cell Therapy 2008 - Brugge
Athanasopoulos, T
Assessment of adenoviral vectors expressing HIV genetic components: Aiming towards a thermo-stable HIV vaccine inducing broad T cell immune responsesUse SHIFT+ENTER to open the menu (new window).
British Society for Gene Therapy 2009 - London
Bachy, V
A vaccination strategy harnessing the adjuvanticity of skin dendritic cells with modified adenoviral vectorsUse SHIFT+ENTER to open the menu (new window).
Society for General Microbiology 2009 - Harrogate
Bachy, V
Development of a 'Stealth' Adenovirus Vaccine VectorUse SHIFT+ENTER to open the menu (new window).
British Society for Gene Therapy 2008 - Edinburgh
Bachy, V
Harnessing skin dendritic cells as a vaccination strategyUse SHIFT+ENTER to open the menu (new window).
Europrise 2008 - Malta
Benlahrech, A
Adenovirus Vectors Induce Expansion of Memory CD4 T Cells with a Mucosal Homing Phenotype that are Readily Susceptible to HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Benlahrech, A
Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
El-Doueik, H
Development of a "Stealth" Adenovirus vaccine vectorUse SHIFT+ENTER to open the menu (new window).
Keystone Meeting 2008 - Banff
Harris, JD
Assessment of Adenoviral Vectors in Gel Formulations for the Manufacture of Micro-Needle Skin PatchesUse SHIFT+ENTER to open the menu (new window).
European Society of Gene and Cell Therapy 2007 - Rotterdam
Papagatsias, T
Using Ubiquitin Fusion to Augment Immune Responses Against HIV-1 AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Papagatsias, T
Using Ubiquitin Fusion to Augment Immune Responses Against HIV-1 AntigensUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Takis, A
Fragmentation, ubiquitination and mosaicism of HIV/SIV genetic components in the context of thermo-stable adenoviral (Ad) vectors as novel vaccine approaches against HIV-1/AIDSUse SHIFT+ENTER to open the menu (new window).
Federation of European Biochemical Societies (FEBS), 2010, Gothenburg, Sweden
Expand/Collapse CAVD Grantee : Plummer GCGH ‎(2)
Herman, M
Optimization of the Expansion of Antigen-Specific CD8+ T-cells for Use in a Viral Suppression AssayUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Richmond, M
Epitope mapping of HIV-specific CD8+ T cell responses by polyfunctional flow cytometry and proliferation responses reveal distinct specificity defined by functionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Reinherz VDC ‎(1)
Song, L
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : Self VISC ‎(2)
Bellew, M
LabKey Software: An Open-Source Repository and Portal for Lab and Clinical DataUse SHIFT+ENTER to open the menu (new window).
BioIT Conference 2008 - Vancouver
Moodie, Z
Statistical Approaches to Analyze Multi-parametric Flow AnalysisUse SHIFT+ENTER to open the menu (new window).
BioIT Conference 2008 - Vancouver
Expand/Collapse CAVD Grantee : Stamatatos VDC ‎(17)
Ban, YA
4e10 epitope-scaffolds mimic the antibody-bound epitope conformationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bjorkman, Pamela
Engineering Immunity against HIV-1Use SHIFT+ENTER to open the menu (new window).
CROI 2010- San Francisco
Carrico, C
A Computationally Designed Immunogen Elicits Potent Anti-V3 Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Klein, JS
Examination of size and avidity in the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10Use SHIFT+ENTER to open the menu (new window).
Keystone 2009
Robinson, JE
Human and Rhesus MAbs Recognizing Distinct Groups of Epitopes that Elicit Neutralizing Antibodies against Autologous HIV-1 StrainsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Sather, DN
Determinants of Cross-reactive neutralizing antibody responses developed during natural HIV-1-infectionUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Schief, B
Computational Design of Immunogens to ‘Re-elicit’ Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
American Crystallographic Association Meeting 2009 - Toronto
Schief, WR
Computational design of non-HIV protein scaffolds presenting conserved HIV-1 neutralization epitopesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2006 - Amsterdam
Schief, WR
Advances in Vaccine ScaffoldsUse SHIFT+ENTER to open the menu (new window).
CROI 2008 - Boston
Sellhorn, G
Expression, purification and antigenic characterization of soluble clade A/B heterotrimeric gp140 Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Sellhorn, G
Engineering and characterization of soluble heterotrimeric gp140- Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2007
Sellhorn, G
Engineering, expression and antigenic and immunogenic characterization of novel soluble clade A/B heterotrimeric gp140-Envelope glycoproteins Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Strong, RK
Masking of MPER Epitopes through Self-AssociationsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Wallace, A
Engineering and characterization of soluble heterotrimeric gp140-Envelope glycoproteins from HIVUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Xu, C
Production, Biophysical Characterization and Structure Determination of Computationally Derived HIV gp140 Epitope-Scaffolds Use SHIFT+ENTER to open the menu (new window).
11th Annual Joint Research Sympoisum 2007 - Seattle
Xu, H
Putative Lipid-phosphate Head Group Binding Site on the Broadly Neutralizing Anti-HIV Antibody 4E10Use SHIFT+ENTER to open the menu (new window).
Keystone 2009
Xu, H
The Specific Phospholipid Binding and Neutralizing Activities of the Anti-HIV Antibody 4E10 are SeparableUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Expand/Collapse CAVD Grantee : von Briesen HSC ‎(26)
Durst, C
ChameleonLab®: A laboratory knowledge and workflow management system based on low temperature electronicsUse SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Fuchs, CC
Development of a 32-bit microcontroller-based cryotank backplane system for use in the "Global HIV Vaccine Research Cryorepository"Use SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Germann, A
Global HIV Vaccine Research Cryorepository – GHRCUse SHIFT+ENTER to open the menu (new window).
2nd Global Vaccine Congress 2008 - Boston
Germann, A
Global HIV Vaccine Research Cryorepository – GHRCUse SHIFT+ENTER to open the menu (new window).
German Society for Virology 2009 - Leipzig
Germann, A
UnknownUse SHIFT+ENTER to open the menu (new window).
19th Annual Meeting of the Society for Virology 2009 - Leipzig
Gilbert, Sarah
Centre for AIDS Reagents – Provision of Reagents for AIDS Vaccine and Microbicide ResearchUse SHIFT+ENTER to open the menu (new window).
EUROPRISE Annual Conference 15-18 November 2010, Tiara Park Atlantic Lisbon, Portugal
Hurley, M.
Programme EVA Centre for AIDS Reagents (CFAR). Use SHIFT+ENTER to open the menu (new window).
Society for General Microbiology Spring 2010 Meeting, Edinburgh, 29 March – 01 April 2010.
Hurley, M.
Programme EVA Centre for AIDS Reagents (CFAR)Use SHIFT+ENTER to open the menu (new window).
Health Protection 2010 Conference, Warwick, 14-15 September 2010
Ihmig, FR
Development of electronic cryovials and electronic cryotank modules for the "Global HIV Vaccine Research Cryorepository"Use SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
Karim Hichri
"RFID system for the identification of biological samples"Use SHIFT+ENTER to open the menu (new window).
Electronics System Integration Technology Conferences ESTC 2010, Berlin Germany, 13-16 Sep
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
German Society for Virology 2009 - Leipzig
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
19th Annual Meeting of the Society for Virology 2009 - Leipzig
Koch, S
Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
IAS 2009 - Cape Town
Koch, S.
“First implementation of an automated cell culture and transfection system for HIV-1 Env-pseudotyped virus production” Use SHIFT+ENTER to open the menu (new window).
“AIDS Vaccine Conference 2010, Atlanta (28 September – 01 October)”
Meyerhans, A
The "Global HIV Vaccine Research Cryorepository": Standardized HIV-1 Env-pseudovirus production under GCLP conditions allows highly concordant global HIV neutralizing antibody assessmentUse SHIFT+ENTER to open the menu (new window).
German-Japanese AIDS Konferenz 2009 - Bochum
Ramaswamy, M
Programme European Vaccine against AIDS (EVA) Centre for AIDS Reagents (CFAR) - A Reagent Resource for HIV and other Infectious DiseasesUse SHIFT+ENTER to open the menu (new window).
ISHEID,  2010, Marseilles
Ramaswamy, M
A Reagent Resource to facilitate Vaccine and Microbicide Discovery and DevelopmentUse SHIFT+ENTER to open the menu (new window).
EUROPRISE, 2009, Budapest
Ramaswamy, M
Programme EVA Centre for AIDS Reagents: A Resource for Research and Reference Reagents and Materials SharingUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Ramaswamy, M.
Programme EVA Centralised Facility for AIDS Reagents (CFAR)Use SHIFT+ENTER to open the menu (new window).
ISHEID, 2010, Marseilles
Schulz, J
Standardized serum-free cryomedia have minimum cytotoxicity and maintain antigen-specific T-cell responseUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Schulz, JC
Development and application of new storage-technologies for effective and secure cryobankingUse SHIFT+ENTER to open the menu (new window).
Medical Physics and Biomedical Engineering 2009 - Manchen
Schulz, JC
Development and application of new storage-technologies for effective and secure cryobankingUse SHIFT+ENTER to open the menu (new window).
Medical Physics and Biomedical Engineering World Congress 2009 - Munich
Schulz. JC
New modular HIV-cryosubstrates for secure and reliable sample identification and DMSO reduction in cryopreserved peripheral blood mononuclear cellsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Shirley, SG
A large-scale cryo-electronic system for biological sample bankingUse SHIFT+ENTER to open the menu (new window).
WOLTE 2008 - Ilmenau, Germany
von Briesen, H
Global HIV Vaccine Research Cryorepository - GHRCUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Expand/Collapse CAVD Grantee : Walker VDC ‎(55)
Addo, M
Increased Tim-3 expression on T cells in chronic HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Allen, T
Ultra-Deep Sequencing of Full-Length HIV-1 Genomes Identifies Rapid Viral Evolution During Acute InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Altfeld, M
Immune recognition of HIV-1 during acute infection Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Angin, M
Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Arcary, Derseree
HIV-1 Subtype C Diversity in an Adult Cohort of Progressors and Non-progressors Using Single Genome AmplificationUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Boutwell, C
Escape Mutations in Gag Associated with Protective HLA Alleles Substantially Impact Viral Replication CapacityUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting, Boston, MA - 2009
Boutwell, CL
CTL Escape Mutations in Gag Epitopes Restricted by Protective HLA Class I Alleles Cause Substantial Reductions in Viral Replication CapacityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Brumme, CJ
Reversion of HLA-associated polymorphisms in Gag, Pol and Nef during the first year of HIV infection: Sites, rates and pVL correlationsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brumme, Z
Combined clinical and immunological biomarkers predict rates of CD4 decline in chronic untreated HIV infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Brumme, ZL
Relationship between HLA class I-driven evolution in Gag, Pol and Nef and clinical markers of HIV disease: a multi-center collaborative studyUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Carrington M
Immunogenetic variation charaterizing exceptional control of HIVUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Carrington M
Immunogenetic effects on HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
Keystone Symposia on Human Immunology and Immunodeficiences 2009 - Beijing
Chang, JJ
TLR-mediated pDC responses to HIV-1 ligandsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Chen, H
HIV-1 elite controllers resist HIV-1 infection via p21 (cip-1/waf-1)Use SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2010; Atlanta, GA
Chevalier, M
Skewed HIV-1-specific CD4+ Th2 helper cell contribution in progressive HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2009; Paris, France
Chevalier, M
Increased control of viral replication by HIV-1-specific CD8+ T cells mediated by HIV-specific CD4+ T helper signalsUse SHIFT+ENTER to open the menu (new window).
HIV Vaccine Keystone, Banff, Canada - 2009
de Bakker, P
Genome-wide Association Analysis Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
de Bakker, P
A Genome-wide Association Study in HIV-1 Controllers Use SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
deBakker, Paul
A Genome-wide Association Study in HIV-1 Controllers Use SHIFT+ENTER to open the menu (new window).
NIH/OAR Genomic Analyses of HIV Infection 2009 - Bethesda
deBakker, Paul
Whole Genome Association Studies: Understanding the Genetic Basis of Susceptibility to Infectious DiseasesUse SHIFT+ENTER to open the menu (new window).
ASTMH 2008 - New Orleans
Dugast, AS
Dramatic changes in Fc-receptor expression during HIV-1 infection associated with reduced phagocytic activity during progressive HIV-1 infection (Poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Heckerman, David
Vaccine-induced Targeting of Epitopes Associated with Spontaneous Control of HIV Viral Replication is Associated with Lower Set-point Viral Loads in HIV-Infected Participants from the STEP TrialUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Henn, M
Ultra-deep Viral Sequencing Reveals Rapid CTL Escape and Reversion Events During Acute HIV-1 InfectionUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Henn, MR
Ultra-Deep Sequencing of Full-Length HIV-1 Genomes Identifies Rapid Viral Evolution During Acute Infection Use SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting 2009 - Boston
Henn, MR
Sensitive Population Profiling and Genome Assembly of HIV Using Ultra-deep Sequencing TechnologiesUse SHIFT+ENTER to open the menu (new window).
CROI 2010 - San Francisco, CA
Henn, MR
Ultra-Deep Sequencing of Full-Length HIV-1 Genomes Identifies Rapid Viral Evolution During Acute InfectionUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting, Boston, MA - 2010
Henn, MR
Ultra-Deep Sequencing Identifies Regions of HIV Undergoing Rapid Selection During Acute HIV InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2009
Henn, MR
Ultra-Deep Sequencing During Acute HIV Infection Reveals the Earliest Adaptive Changes to Host Selection Pressures.Use SHIFT+ENTER to open the menu (new window).
17th International HIV Dynamics & Evolution Conference, Monterery, California, April 2010
Jen, D
Comparative Viral Genome Visualization (Poster)Use SHIFT+ENTER to open the menu (new window).
IEEE Information Visualization Conference (IEEE InfoVis) - Atlantic City
Jia, X
Next-generation Sequencing for HLA Typing and MHC Sequence Interrogation for Host Genetics of HIV InfectionUse SHIFT+ENTER to open the menu (new window).
CROI 2010 - San Francisco, CA
Julg, B
Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Julg, B
HLA Class II Allele DRB1*1303 Is Associated with Reduced Viral Loads in 2 Independent Cohorts of Different Ethnicity and HIV Clades of InfectionUse SHIFT+ENTER to open the menu (new window).
CROI 2010 - San Francisco, CA
Kavanagh, DG
Unique spectrum of pro-and anti-inflammatory molecules induced on DCs by simultaneous stimulation with TLR8 plus TLR3 or TLR4 ligandsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Kwon, D
new technologies to better understand spontaneous control of HIV (Oral Presentation)Use SHIFT+ENTER to open the menu (new window).
Unlocking the Mystery of the HIV Controller Symposium 2009 - San Francisco
Kwon, DS
The Role of CD4+ CD25+ Regulatory T Cells in the Control of IL-10 Mediated T cell Impairment in Chronic HIV InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Lazaro, E
The intracellular production of HIV antigenic peptides is guided by predictable motifs and can be altered: implications for immunogen designUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Lazaro, E; Zhang SC
Predictable motifs guide the intracellular production of HIV antigenic peptidesUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting 2009 - Boston
Li, C
Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Malboeuf, C
Capturing intra-host diversity of viral genomes using “next-generation” sequencing technology Use SHIFT+ENTER to open the menu (new window).
Next-Generation Sequencing Data Analysis 2009 - Providence RI
Ndhlovu, Z
Mosaic HIV-1 Gag antigens can accurately present major HIV-specific epitopes in human cells.Use SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2010; Atlanta, GA
Nolting, A
MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunctionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Oniangue-Ndza C
Impact of CTL Escape Mutations in HIV-1 Nef on Viral Replication.Use SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2009; Paris, France
Oniangue-Ndza, C
Impact of CTL Escape Mutations in HIV-1 Nef on Viral Replication (poster)Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Pereyra, F
Epitope specific CD8+ T-cell responses predict spontaneous HIV virus replicationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Pyo, A
Skewed HIV-1-specific CD4+ Th2 helper cell contribution in progressive HIV-1 infectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Ranasinghe, S
Marked differences in the immunodominance pattern of HIV-1-specific CD4+ T cell responses in subjects spontaneously controlling HIV-1 infectioUse SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2010; Atlanta, GA
Schneidewind, A
Long-term Stability of Compensated CTL Escape Mutations following Acute HIV InfectionUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Schneidewind, A
Identification of Subdominant CD8+ Responses Selecting CTL Escape Mutations in Gag that Impair HIV ReplicationUse SHIFT+ENTER to open the menu (new window).
Keystone 2009
Skaria, Amy
Compartmentalization of Drug Resistance, Immune Escape, and Co-receptor Tropism in Circulating Plasma Viruses during Late-stage HIV InfectionUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal
Streeck, H
Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Streeck, H
The First Emerging CD8 T Cell Responses Are a Major Determinant of Early Viral Set-PointUse SHIFT+ENTER to open the menu (new window).
CROI 2009 - Montreal, Canada
Streeck, H
Prevalent HLA Class I Allele Combinations Result in a Lack of HIV-1-Specific CD8+ T Cell Responses and Higher Viral Set PointUse SHIFT+ENTER to open the menu (new window).
HIV Acute Infection Meeting, Boston, MA - 2009
Streeck, H
Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion moleculesUse SHIFT+ENTER to open the menu (new window).
AIDS VACCINE - 2009; Paris, France
Streeck, H
Prevalent HLA class I allele combinations result in a lack of HIV-1-specific CD8+ T cell responses and higher viral set point Use SHIFT+ENTER to open the menu (new window).
HIV Vaccine Keystone, Banff, Canada - 2009
Streeck, H; Kwon, DS
The epithelial adherens junction protein E-cadherin inhibits HIV-1-specific CD8+ T cell responses by binding to KLRG1 Use SHIFT+ENTER to open the menu (new window).
International Congress of Mucosal Immunology 2009 - Boston
Expand/Collapse CAVD Grantee : Weiss VDC ‎(9)
Balla-Jhagjhoorsingh, S
New neutralizing monoclonal antibodies from HIV-1 subtype C and CRF02_AG infected peopleUse SHIFT+ENTER to open the menu (new window).
Ehrlich 2008 - Germany
Balla-Jhagjhoorsingh, S
The importance of well-defined HIV-1 neutralization assaysUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Benen, T
An HIV-1-based screening platform for selection of envelopes with high affinity for broadly neutralizing antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Bruun, TH
Cell-surface Display and Panning of HIV-1 derived Envelope proteinsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Hinz, A
Immunogenicity and Neutralization Properties of a Trimeric MPER Containing gp41 AntigenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Isaksen, A
Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patientsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Jhagjhoorsingh, SB
Strong and potent neutralizing IgG memory B cells in HIV-1 subtype C and CRF02_AG infected individualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Schilling, K
Generation of a HI-viral packaging cell line as scaffolding for a lentiviral display systemUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Weiss, RA
Llama antibody fragments with broad HIV-1 crossneutralizing activityUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Expand/Collapse CAVD Grantee : Zolla-Pazner VDC ‎(19)
Agarwal, A
Structural Model of gp120 Surface of Infection Based on Positional Charge Differences between X4- and R5-tropic virusesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Alam, SM
HIV-1 Env gp41 Abs that mask neutralizing epitopes - production in HIV-1 infection and potential for reg of gp41 MPER NAbsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Almond, D
Dynamic Characterization of the V3 Loop CrownUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Almond, D
Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone Use SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Burda, S
Evolution of HIV-1 subtype B viruses and neutralization patterns with heterologous anti-HIV-1 antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Burke, V
Structural Characterization of Neutralizing Human Anti-V3 Monoclonal Antibodies 3074 and 268-DUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Cardozo, T
Structural Basis for Coreceptor Selectivity by the HIV Type 1 V3 LoopUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Cardozo, T
Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Gorny, MK
Immunoglobulin Gene Usage by Neutralizing Human Anti-V3 HIV-1 Monoclonal Antibodies Derived from Clade B and Non-B HIV-1-infected IndividualsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Gorny, MK
Human anti-V3 monoclonal antibodies (mAbs) from non-clade B-infected individuals display cross-clade neutralizationUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Gorny, MK
Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Jiang, X
Structural Basis of the Antibody-Antigen Interaction in Human Anti-V3 HIV-1 Monoclonal AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Jiang, X
Crystal Structures of HIV-1 Neutralizing Anti-V3 Monoclonal Antibody 2557 in Complex with V3 PeptidesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Jiang, Xunqing
Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crownUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Krachmarov, C
Effects of V3 Variation and V1-V2 Masking on Neutralization on a Panel of Tier 2 Clade B Envs by V3-Specific MAbs and PAbsUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Zolla-Pazner, S
Induction of Cross-clade, Anti-V3 Neutralizing Antibodies in Rabbits Using a DNA Prime/Protein Boost Immunization RegimenUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2008 - Cape Town
Zolla-Pazner, S
Focusing the Immune Response on the V3 Loop of the HIV-1 gp120 Envelope Induces Cross-Clade Neutralizing AntibodiesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2007 - Seattle
Zolla-Pazner, S
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypesUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris
Zolla-Pazner, S
Induction of Cross-clade Neutralizing Antibodies with a Prime/Boost Vaccine Strategy Focused on a Neutralizing EpitopeUse SHIFT+ENTER to open the menu (new window).
AIDS Vaccine 2009 - Paris